Showing results (101-110 of 150) with videos related to

Sort By:
Pageof 15
European Urology|January 28, 2022
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial CarcinomaJ Alberto Nakauma-González, Maud Rijnders, Job van Riet, et al.
Genome Medicine|October 18, 2019
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosisJoep J de Jong, Yang Liu, A Gordon Robertson, et al.
Molecular Oncology|March 14, 2025
Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancerKhrystany T Isebia, Anouk C de Jong, Lisanne F van Dessel, et al.
European Urology|April 28, 2026
European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines UpdateArie Parnham, Maarten Albersen, Benjamin Ayres, et al.
The American Journal of Surgical Pathology|September 17, 2019
Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder CarcinomaCharlotte S Voskuilen, Htoo Zarni Oo, Vera Genitsch, et al.
ESMO Open|December 6, 2024
Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trialJ E Rosenberg, M D Galsky, T Powles, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trialThomas Powles, Mark Kockx, Alejo Rodriguez-Vida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2024
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer MicroenvironmentMaksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe, et al.
The New England Journal of Medicine|September 16, 2024
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder CancerThomas Powles, James W F Catto, Matthew D Galsky, et al.
European Urology Oncology|March 25, 2020
Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific DifferencesJoep J de Jong, Joost L Boormans, Bas W G van Rhijn, et al.
Pageof 15